Ad
related to: cancer parasitic drug resistance
Search results
Results From The WOW.Com Content Network
RELATED: Malaria parasites can beat down cancer: Malaria Parasites Can Be Used To Help Beat Down Drug-Resistant Parasites. Show comments. Advertisement. Advertisement. In Other News.
This protein stimulates the growth of cancer cells which are drug-resistant. [12] MicroRNAs have also been shown to affect acquired drug resistance in cancer cells and this can be used for therapeutic purposes. [13] Malaria in 2012 has become a resurgent threat in South East Asia and sub-Saharan Africa, and drug-resistant strains of Plasmodium ...
In cancer cells, where normal regulation of gene expression breaks down, the oncogenes are activated via hypomethylation and tumor suppressors are silenced via hypermethylation. Similarly, in drug resistance development, it has been suggested that epigenetic modifications can result in the activation and overexpression of pro-drug resistance genes.
Multiple drug resistance (MDR), multidrug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to at least one antimicrobial drug in three or more antimicrobial categories. [1] Antimicrobial categories are classifications of antimicrobial agents based on their mode of action and specific to target ...
Carcinogenic parasites are parasitic organisms that depend on other organisms (called hosts) for their survival, and cause cancer in such hosts.Three species of flukes are medically-proven carcinogenic parasites, namely the urinary blood fluke (Schistosoma haematobium), the Southeast Asian liver fluke (Opisthorchis viverrini) and the Chinese liver fluke (Clonorchis sinensis).
Overuse or misuse of antiparasitics can lead to the development of antimicrobial resistance. Broad-spectrum antiparasitics, analogous to broad-spectrum antibiotics for bacteria, are antiparasitic drugs with efficacy in treating a wide range of parasitic infections caused by parasites from different classes.
Its macrocyclic structure was designed specifically to address some of the most recalcitrant resistance mutations. Still, most tumours eventually develop resistance through various mechanisms, namely compound-mutations (two or three mutations simultaneously) or activation of alternative pathways, such as the c-MET pathway.
Man, 30, diagnosed with colon cancer after feeling stomach pain. Doctors explain colorectal cancer symptoms in younger people, how to self advocate. Chef, 30, was told his stomach pain was food ...
Ad
related to: cancer parasitic drug resistance